Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

BNGO
Bionano Genomics, Inc. Common Stock
stock NASDAQ

At Close
Jul 31, 2026 3:59:53 PM EDT
1.07USD+0.472%(+0.01)239,800
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 31, 2026 8:05:30 AM EDT
1.08USD+2.075%(+0.02)100
After-hours
Jul 31, 2026 4:53:30 PM EDT
1.06USD-0.469%(-0.01)4,586
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
08:00AM EST  -- Whole genome analysis by OGM together with analysis using a 523-gene NGS panel can perform better and cost less than analysis with karyotyping, FISH, and a 54-gene NGS panel -- Firststudy to publish results using NxClinical software for simultaneous visualization and interpretation of sequence and copy number variants from NGS and OGM data   GlobeNewswire Inc
Jan 20, 2022
08:00AM EST  Bionano Genomics Announces Publication by International COVID-19   GlobeNewswire Inc
Jan 19, 2022
10:51PM EST  UPDATE -- Bionano Genomics Announces its Support for the ACMG   GlobeNewswire Inc
09:36PM EST  Bionano Genomics Announces its Support for the AGMG Foundation for   GlobeNewswire Inc
08:00AM EST  -- Average daily attendance of 565 in 2022 versus 346 in 2021 -- Over 4,000 registrants with attendees represented from 82 countries -- 31 oral presentations delivered across four consecutive days -- 37 scientific posters featuring OGM in the online exhibit hall -- On-demand presentations from Symposium available for remainder of 2022   GlobeNewswire Inc
Jan 13, 2022
06:18PM EST  Bionano Genomics Hosts Final Day of 2022 Symposium with   GlobeNewswire Inc
Jan 12, 2022
04:30PM EST  Bionano Genomics Hosts Day 3 of 2022 Symposium with New Research   GlobeNewswire Inc
12:15PM EST  Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations   Benzinga
08:10AM EST  Bionano Genomics Sees Prelim. Q4 Revenue $5.8M-$6.2M vs $5.44M Est.   Benzinga
08:00AM EST  - Preliminary Q4 revenue expected between $5.8 and $6.2 million; 45%-55% increase over Q4 2020   GlobeNewswire Inc
Jan 11, 2022
05:12PM EST  Bionano Genomics Hosts Day 2 of 2022 Symposium with New Research   GlobeNewswire Inc
Jan 10, 2022
07:49PM EST  UPDATE - Bionano Genomics Hosts Day 1 of 2022 Symposium with Six   GlobeNewswire Inc
06:26PM EST  Bionano Genomics Hosts Day 1 of 2022 Symposium with Six   GlobeNewswire Inc
08:32AM EST  Bionano Genomics Announces Publication Of Interim Readout From Consortium Conducting Postnatal Clinical Trial Intended To Support Establishing Optical Genome Mapping As Part Of Standard Of Care In Genetic Disease Diagnosis   Benzinga
08:00AM EST  IRB-approved, multi-site, ongoing study evaluated 331 individual sample runs from 202 unique samples across 5 sites for interim measures of key endpoints:   GlobeNewswire Inc
Jan 7, 2022
08:00AM EST  Bionano Genomics Announces the Final Speaker Lineup for 2022 Symposium   GlobeNewswire Inc
Dec 29, 2021
08:00AM EST  Bionano Announces Prototype for its Next Single Molecule Imaging   GlobeNewswire Inc
Dec 23, 2021
08:00AM EST  University Hospitals Leuven in Belgium Outlines their Menu   GlobeNewswire Inc
Dec 22, 2021
08:05PM EST  Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr system and provider of the leading software solutions for visualization, interpretation and reporting of genomic data, today announced the appointment of Vincent Wong, JD, MBA, to its board of directors.   GlobeNewswire Inc
Dec 16, 2021
08:30AM EST  Bionano Genomics Announces Launch Of Version 6.1 Of BioDiscovery's NxClinical Software For Genome Analysis With Expanded Capabilities For Visualization, Interpretation And Reporting Of Next-Generation Sequencing Data In Genetic Diseases and Cancer   Benzinga
08:00AM EST  Bionano Genomics Announces the Launch of Version 6.1 of   GlobeNewswire Inc
Dec 9, 2021
09:47PM EST  Bionano Genomics Announces 2022 Symposium Jan. 10-13   Benzinga
08:00AM EST  Bionano Genomics Announces 2022 Symposium Featuring Four   GlobeNewswire Inc
Dec 8, 2021
08:05AM EST  Bionano Genomics Announces Publication Of Study Evaluating Optical Genome Mapping For High Throughput Characterization Of Cytogenomic Heterogeneity In MDS   Benzinga
08:00AM EST  Bionano Genomics Announces Publication of Study Evaluating Optical   GlobeNewswire Inc
Nov 29, 2021
08:00AM EST  Bionano Genomics Appoints Dr. Keith Gligorich, Seasoned Leader in   GlobeNewswire Inc
Nov 22, 2021
08:05AM EST  Bionano Genomics Announces Peer-Reviewed Publication From Johns Hopkins University Outlining A Stepwise Approach To The Adoption Of Optical Genome Mapping For Cancer Analysis   Benzinga
08:00AM EST  Bionano Genomics Announces Peer-Reviewed Publication from Johns   GlobeNewswire Inc
Nov 15, 2021
11:07AM EST  Bionano Genomics Announces Extensive Lineup Of Content To Be Presented At The Annual Meeting Of The Association For Molecular Pathology Featuring Optical Genome Mapping Across A Broad Range Of Clinical Research Applications   Benzinga
08:00AM EST  Bionano Genomics Announces Extensive Lineup of Content to be   GlobeNewswire Inc
Nov 5, 2021
09:31AM EDT  Bionano Genomics Q3 Net Loss $20.753M, Sales $4.66M Beat $4.23M Estimate   Benzinga
Nov 4, 2021
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
08:00AM EDT  Bionano Genomics Announces the Appointment of Stephanie Hoyle as   GlobeNewswire Inc
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Nov 3, 2021
09:19AM EDT  Bionano Genomics Highlights Updates To Its Solve, Access Data Solutions   Benzinga
08:00AM EDT  Bionano Genomics Announces Major Updates to Its   GlobeNewswire Inc
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 20, 2021
08:07AM EDT  Bionano Genomics Says Presentation At ASHG Showcases New Capabilities For Optical Genome Mapping With Detection Of Allelic Imbalance And Absence Of Heterozytgosity Further Expanding Its Utility In Revealing More Clinically Relevant Variants   Benzinga
08:00AM EDT  Presentation at ASHG Showcases New Capabilities for Optical Genome   GlobeNewswire Inc
Oct 18, 2021
12:58PM EDT  Bionano Genomics Option Alert: Jan, 2023 $10 Calls Sweep (5) near the Ask: 260 @ $1.19 vs 4799 OI; Earnings 11/11 After Close [est] Ref=$5.2683   Benzinga
Oct 15, 2021
08:01AM EDT  Bionano Genomics Announces American Society Of Human Genetics Presentations Oct. 18-22   Benzinga
08:00AM EDT  Bionano Genomics Announces American Society of Human Genetics   GlobeNewswire Inc
Oct 14, 2021
08:02AM EDT  Bionano Genomics Announces Study Shows The Combination Of OGM And NGS With Linked-Reads Detects Significantly More Clinically Relevant Variants Resulting In Higher Success Rates For Resolving Previously Unclassified Subjects In Genetic Disease Research   Benzinga
08:00AM EDT  Study Shows the Combination of OGM and NGS with Linked-Reads   GlobeNewswire Inc
Oct 12, 2021
07:46AM EDT  Bionano Genomics To Acquire BioDiscovery For Consideration Of Up To $100M   Benzinga
07:45AM EDT  -- Designed to accelerate the adoption of optical genome mapping (OGM) with the integration of BioDiscoverys NxClinical software solution for variant analysis   GlobeNewswire Inc
Oct 6, 2021
08:00AM EDT  BionanoGenomics Expands Commercial Leadership Team to   GlobeNewswire Inc
Sep 29, 2021
08:22AM EDT  Bionano Genomics Announces The Publication Of Clinical Research Study To Date Evaluating Optical Genome Mapping For Facioscapulohumeral Muscular Dystrophy   Benzinga
08:00AM EDT  Largest Clinical Research Study to Date Evaluating Optical Genome   GlobeNewswire Inc
Sep 16, 2021
08:21AM EDT  Bionano Genomics Announces Study Finds The Combination Of Optical Genome Mapping And Short-Read Sequencing Provides A Comprehensive Genome Analysis For Lung Cancer Samples And Enables The Discovery Of New Biomarkers   Benzinga
08:00AM EDT  Study Finds the Combination of Optical Genome Mapping and   GlobeNewswire Inc
Sep 7, 2021
08:15AM EDT  Bionano Genomics Announces NuProbe Global Has Adopted Bionano's Saphyr System To Develop Products In Reproductive Health And Oncology Applications   Benzinga
08:00AM EDT  NuProbe Global Adopts Bionanos   GlobeNewswire Inc
Aug 26, 2021
08:00AM EDT  Bionano Genomics Announces ESHG Lineup Featuring 11 Customer   GlobeNewswire Inc
Aug 20, 2021
10:41AM EDT  Bionano Genomics Option Alert: Sep 17 $5 Calls Sweep (32) near the Ask: 500 @ $0.75 vs 826 OI; Ref=$5.3511   Benzinga
Aug 4, 2021
05:19PM EDT  Bionano Genomics Q2 Sales $3.90M Beat $3.52M Estimate   Benzinga
04:05PM EDT  -- 226% year-over-year total revenue increase driven by growth in the Saphyr installed base -- All 2021 milestones on track -- Strong balance sheet with $333 million in cash as of June 30, 2021 -- Conference call today, Wednesday, August 4, at 4:30 pm ET   GlobeNewswire Inc
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 29, 2021
10:17AM EDT  Bionano Genomics Files For U.S. Patent Titled 'LABELING OF DNA'   Benzinga
Jul 27, 2021
11:13AM EDT  Bionano Genomics Reports Number Of Presentations On Optical Genome Mapping Between Aug. 1-4   Benzinga
Jul 19, 2021
08:06AM EDT  Bionano Genomics Highlights Co's Optical Genome Mapping For Acute Lymphoblastic Leukemia   Benzinga
08:00AM EDT  Bionanos Optical Genome Mapping for Acute   GlobeNewswire Inc
Jul 14, 2021
08:00AM EDT  Bionanos Optical Genome Mapping Reveals New   GlobeNewswire Inc
Jul 13, 2021
08:01AM EDT  Bionano Genomics Highlights Optical Genome Mapping Featured At 2021 European Cytogenomics Conference   Benzinga
Jul 7, 2021
11:26AM EDT  Cramer Gives His Opinion On RadNet, Nano Dimension And More   Benzinga
11:01AM EDT  Bionano Genomics Highlights Back-To-Back Publications In American Journal Of Human Genetics Comparing Original Genome Mapping to Traditional Methods For Structural Variant Analysis In Structural Variant Analysis   Benzinga
11:00AM EDT  Bionano Genomics Announces Back-to-Back Publications in the   GlobeNewswire Inc
Jul 6, 2021
08:08AM EDT  Bionano Genomics Highlights WeHealth Shanghai's Adoption Pf Bionano's Saphyr System   Benzinga
08:00AM EDT  Bionano Genomics Announces Significant Progress in China with   GlobeNewswire Inc
Jul 2, 2021
08:00AM EDT  Bionano Genomics Chief Medical Officer Dr. Alka   GlobeNewswire Inc
Jul 1, 2021
04:05PM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the 2021 Ladenburg Thalmann Healthcare Conference being held July 13-14, 2021. Erik Holmlin, PhD, Bionanos Chief Executive Officer, will present a company overview on July 13, 2021 at 4:30pm EDT.   GlobeNewswire Inc
Jun 28, 2021
08:13AM EDT  Bionano Genomics Added To Membership Of US Small-Cap Russell 2000 Index   Benzinga
08:00AM EDT  Bionano Genomics Added to Membership ofUS Small-Cap   GlobeNewswire Inc
Jun 16, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021   Benzinga
07:50AM EDT  BTIG Initiates Coverage On Bionano Genomics with Buy Rating, Announces Price Target of $10   Benzinga
Jun 15, 2021
11:27AM EDT  Bionano Genomics Option Alert: Jan 21 $8 Calls Sweep (5) near the Ask: 202 @ $2.84 vs 2932 OI; Earnings 8/12 After Close [est] Ref=$7.5899   Benzinga
Jun 14, 2021
08:28AM EDT  Bionano Genomics Names Richard Shippy Chief Business Officer   RTTNews
08:00AM EDT  Bionano Genomics Appoints Richard Shippy, Former Affymetrix,   GlobeNewswire Inc
Jun 9, 2021
10:06AM EDT  Bionano Genomics Option Alert: Aug 20 $6 Calls at the Ask: 1100 @ $3.101 vs 3154 OI; Ref=$8.1732   Benzinga
Jun 8, 2021
08:47AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jun. 8, 2021: NIO, BNGO, WKHS, PLUG, UONE   Benzinga
Jun 7, 2021
10:05AM EDT  Shares of Bionano Genomics, Inc. (BNGO) are currently gaining over 18% as the company named Jason Priar as its chief commercial officer.   RTTNews
08:00AM EDT  Bionano Genomics Appoints Jason Priar, Former GeneDx, Sema4 and   GlobeNewswire Inc
Jun 1, 2021
10:31AM EDT  Bionano Genomics Option Alert: Nov 19 $7 Calls at the Ask: 200 @ $1.49 vs 1163 OI; Ref=$5.973   Benzinga
May 24, 2021
10:36AM EDT  Bionano Genomics Tweets 'Dr. Alex Hoischen, Radboud University, presented on his research use of optical genome mapping (OGM) with the Saphyr system to solve undiagnosed genetic disease cases, reporting a preliminary 25% additional diagnostic yield...'   Benzinga
May 20, 2021
10:06AM EDT  Bionano Genomics US Patent & Trademark Office Abstract For Co.'s 'REDUCTION OF BIAS IN GENOMIC COVERAGE MEASUREMENTS'   Benzinga
May 19, 2021
04:08PM EDT  Bionano Genomics To Present At 2021 Oppenheimer MedTech, Tools & Diagnostic Summit May 26   Benzinga
04:05PM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Oppenheimer MedTech, Tools & Diagnostics Summit being held on May 26, 2021.   GlobeNewswire Inc
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 13, 2021
04:09PM EDT  Bionano Genomics Q1 Net Loss $9.95M vs Net Loss $10.5M In Same Qtr. Last Year, Sales $3.20M Beat $2.90M Estimate   Benzinga
04:01PM EDT  -- 179% year-over-year revenue increase driven by record sales of consumables and growth in the Saphyr installed base -- All 2021 milestones on track -- Strong balance sheet with $362 million cash as of March 31, 2021 -- Conference call today, Thursday, May 13, at 4:30 pm ET   GlobeNewswire Inc
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 4, 2021
08:13AM EDT  Bionano Genomics Announces Issuance Of US Patent For Targeted Labeling Strategy To Complement Whole Genome Analysis Using Optical Genome Mapping   Benzinga
08:00AM EDT  Bionano Genomics Announces Issuance of US Patent for Targeted   GlobeNewswire Inc
May 3, 2021
08:23AM EDT  Bionano Genomics Announces Announces Georgia Esoteric And Molecular Laboratory At The Medical College Of Georgia Is Offering Diagnostic Services Based On Optical Genome Mapping With Saphyr System   Benzinga
08:00AM EDT  Georgia Esoteric and Molecular Laboratory at Augusta University   GlobeNewswire Inc
Apr 22, 2021
08:05AM EDT  Bionano Genomics Announces Publication of New Approach to Study DNA Replication Using Optical Genome Mapping With Saphyr, Potentially Supporting Development of Cancer Drugs Targeting Replication Pathways   Benzinga
08:00AM EDT  Bionano Genomics Announces Publication of New Approach to Study   GlobeNewswire Inc
Apr 21, 2021
08:07AM EDT  Bionano Genomics Says Sites Within UK's National Health System Have Adopted Co's Saphyr System For Optical Genome Mapping   Benzinga
08:00AM EDT  Bionano Genomics Announces Sites within the UKs   GlobeNewswire Inc
Apr 14, 2021
08:05AM EDT  Bionano Genomics Reports Pre-Clinical Evaluation Of Optical Genome Mapping By Foundation For Embryonic Competence   Benzinga
08:00AM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) announced the launch of an IRB-approved preclinical evaluation study using optical genome mapping (OGM) by the Foundation for Embryonic Competence (FEC) based in Basking Ridge, NJ. FEC is a nonprofit organization providing preimplantation embryo diagnostic tests for patients who are undergoing in vitro fertilization (IVF).   GlobeNewswire Inc
Apr 12, 2021
08:04AM EDT  Bionano Genomics Announces 'Record Number Of Presentations' On Optical Genome Mapping And Structural Variation At 2021 Annual Clinical Genetics Meeting Of The ACMG   Benzinga
08:00AM EDT  Bionano Genomics Announces Record Number of Presentations on   GlobeNewswire Inc
Apr 8, 2021
10:40AM EDT  Bionano Genomics US Patent & Trademark Office Abstract For Co.'s 'INTEGRATED ANALYSIS DEVICES AND RELATED FABRICATION METHODS AND ANALYSIS TECHNIQUES'   Benzinga
Apr 7, 2021
04:31PM EDT  Bionano Genomics Reports Will Present On Optical Genome Mapping At American Association for Cancer Research Meeting Apr. 14, 2021 1-2 p.m. EDT   Benzinga
04:30PM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that multiple studies on the detection of structural variants using Bionanos optical genome mapping, including a Spotlight Presentation, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, which is being held in a virtual format April 10-15, 2021.   GlobeNewswire Inc
08:14AM EDT  Bionano Genomics Announces Expansion In Adoption Of Saphyr System With Addition Of Indalo Bio In South Africa   Benzinga
08:00AM EDT  Bionano Genomics Announces Continued Global Expansion in Adoption   GlobeNewswire Inc
Apr 6, 2021
08:04AM EDT  Bionano Genomics Says Publication Outlines Potential For Optical Genome Mapping With Co's Saphyr System To Be Foundation Of A New Workflow In Prenatal Genetic Testing   Benzinga
08:00AM EDT  Publication Outlines Potential for Optical Genome Mapping with   GlobeNewswire Inc
Mar 24, 2021
04:20PM EDT  Bionano Genomics May Offer And Sell Shares Having Offering Price Of Up To $350M   Benzinga
08:59AM EDT  The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping   Benzinga
Mar 23, 2021
05:05PM EDT  Bionano Genomics: Q4 Earnings Insights   Benzinga
04:02PM EDT  Bionano Genomics Q4 Sales $4.00M Beat $3.50M Estimate   Benzinga
04:01PM EDT  -Solidified Financial Position Raising Approximately $335 Million in Q1 2021   GlobeNewswire Inc
08:18AM EDT  The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO   Benzinga
04:26AM EDT  Earnings Scheduled For March 23, 2021   Benzinga
Mar 22, 2021
04:39PM EDT  What's Moving The Market Monday?   Benzinga
10:04AM EDT  Earnings Preview: Bionano Genomics   Benzinga
Mar 15, 2021
08:30AM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences:   GlobeNewswire Inc
Mar 10, 2021
05:02PM EST  Bionano Genomics Presented at H.C. Wainwright Global Life Sciences   GlobeNewswire Inc
Mar 9, 2021
04:30PM EST  Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 23rd, 2021 at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2020 and to highlight recent corporate progress.   GlobeNewswire Inc
Mar 3, 2021
09:21AM EST  Bionano Genomics Says Co's Customer PRaxis Genomics Receives DEX Z-Codes From Palmetto For Their Whole Genome Analysis LDT On Saphyr   Benzinga
09:07AM EST  Bionano Customer Praxis Genomics Receives DEX Z-Codes from   GlobeNewswire Inc
Mar 2, 2021
08:22AM EST  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Cowen 41st Annual Health Care Conference. Erik Holmlin, PhD, Bionanos Chief Executive Officer, is scheduled to present on Thursday, March 4, 2021 at 2:10 pm EST.   GlobeNewswire Inc
Mar 1, 2021
08:00AM EST  Bionano to be Featured at AGBT 2021 with Presentations of   GlobeNewswire Inc
Feb 25, 2021
05:33PM EST  Bionano Genomics Highlights Publication In Science Journal Of A Study By Human Genome Structural Variation Consortium Using Co.'s Saphyr   Benzinga
Feb 22, 2021
08:05AM EST  Bionano Genomics Highlights Publication Of Study By Its Lineagen Team That Describes First Genome-Wide Model To Assess, Score Nearly All Protein-Coding Genes Based On Likelihood To Cause Central Nervous System Disease   Benzinga
08:00AM EST  Bionano Publishes Method for Identifying Genes Likely to Cause   GlobeNewswire Inc
Feb 17, 2021
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
Feb 16, 2021
12:46PM EST  43 Stocks Moving In Tuesday's Mid-Day Session   Benzinga
Feb 11, 2021
04:42PM EST  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Erik Holmlin, PhD, Bionanos Chief Executive Officer, is scheduled to participate in a fireside chat on Thursday, February 18, 2021 at 1:30 pm PST.   GlobeNewswire Inc
08:00AM EST  Method for Solid Tumor Analysis with Saphyr Published by Penn   GlobeNewswire Inc
Feb 9, 2021
08:15AM EST  Hudson Bay Capital Management Reports In 13G Filing A 1.24% Stake In Bionano Genomics   Benzinga
08:13AM EST  Bionano Says Largest Hospital Diagnostic Lab In Canada Pilot's Co's Saphyr System   Benzinga
08:00AM EST  Largest Hospital Diagnostic Lab in Canada Pilots   GlobeNewswire Inc
Feb 5, 2021
08:09AM EST  Bionano Genomics Highlights Presentation Recordings From Co.'s Next-Gen Cytogenomics Symposium Now Available   Benzinga
08:00AM EST  Presentation Recordings from Bionanos   GlobeNewswire Inc
Feb 4, 2021
12:18PM EST  ROCE Insights For Bionano Genomics   Benzinga
Feb 2, 2021
08:11AM EST  Bionano Genomics Announces Publication Of Study That Measured DNA Methylation Of Various Regions Regulating Cancer Genes On Single DNA Modules   Benzinga
08:01AM EST  Saphyr Study Is First to Analyze Cancer Regulation at Level of   GlobeNewswire Inc
Jan 29, 2021
08:00AM EST  Dr. Gordana Raca from Childrens Hospital Los   GlobeNewswire Inc
Jan 27, 2021
08:06AM EST  Bionano Genomics Highlights Chief Medical Officer Presentation At The Festival of Genomics & Biodata   Benzinga
08:00AM EST  Bionano Chief Medical Officer Presents Vision for Optical Genome   GlobeNewswire Inc
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 26, 2021
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
08:00AM EST  Bionano Significantly Reduces Analysis Cost and Time to Actionable   GlobeNewswire Inc
Jan 25, 2021
08:00AM EST  Bionano Genomics Announces Closing of $230 Million Underwritten   GlobeNewswire Inc
Jan 22, 2021
11:08AM EST  Cramer Advises Viewers On Clover, Nio And More   Benzinga
Jan 20, 2021
07:46AM EST  Bionano Genomics Announces Pricing Of $200M Underwritten Public Offering Of Common Stock At $6/Share   Benzinga
07:45AM EST  Bionano Genomics Announces Pricing of $200 Million Underwritten   GlobeNewswire Inc
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 19, 2021
04:25PM EST  Bionano Genomics Announces Proposed Underwritten Public Offering Of Common Stock   Benzinga
04:25PM EST  Bionano Genomics Announces Proposed Underwritten Public Offering   GlobeNewswire Inc
04:14PM EST  Bionano Genomics Files For Mixed Shelf Offering; Size Not Disclosed   Benzinga
08:07AM EST  Bionano Genomics Reports MD Anderson Cancer Center Publishes On Co.'s Saphyr System   Benzinga
08:00AM EST  MD Anderson Cancer Center Publication Shows How   GlobeNewswire Inc
Jan 18, 2021
07:00PM EST  Day Five of Bionanos Next-Generation   GlobeNewswire Inc
Jan 15, 2021
08:14AM EST  Day Four of Bionano's Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy Testing   Benzinga
08:00AM EST  Day Four of Bionanos Next-Generation   GlobeNewswire Inc
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 14, 2021
08:08AM EST  Bionano Genomics Highlights Day 3 Of Its 5-Day Next-Gen Cytogenomics Symposium Featured 6 Saphyr Users Presenting Results, Experiences With Saphyr   Benzinga
08:00AM EST  Day Three of Bionanos Next-Generation   GlobeNewswire Inc
Jan 13, 2021
04:01PM EST  Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price   GlobeNewswire Inc
08:00AM EST  Day Two of Bionanos Next-Generation Cytogenomics   GlobeNewswire Inc
Jan 12, 2021
05:04PM EST  Bionano Genomics Announces Closing of $101.8 Million Underwritten   GlobeNewswire Inc
09:02AM EST  Bionano Genomics Reports Day 1 Of Its 5-Day Next-Gen Cytogenomics Symposium Featured 6 Saphyr Users Presenting Results, Experiences With System   Benzinga
09:00AM EST  -- Path to LDT for prenatal genetic test of positive NIPT cases presented -- 100% concordance with standard cytogenetic and molecular methods in genetic diseases reported -- Resolution of undiagnosed rare diseases using OGM in US, Europe and China described -- Inter-site/operator/instrument reproducibility and 100% data concordance measured   GlobeNewswire Inc
Jan 11, 2021
08:09AM EST  Bionano Genomics Highlights COVID-19 Host Genome SV Consortium Identifies Structural Variants With Possible Roles In Pathogenesis And Outcomes In Severely Ill COVID-19 Patients Using Co's Saphyr System   Benzinga
08:00AM EST  COVID-19 Host Genome SV Consortium Identifies Structural Variants   GlobeNewswire Inc
05:52AM EST  Bionano Genomics Announced on Sunday, The Kick-Off of its Next-Generation Cytogenomics Symposium, The Largest Event Yet to Showcase Saphyr's Utility in Genome Analysis for Genetic Disease and Cancer   Benzinga
Jan 10, 2021
07:14PM EST  Bionano Genomics Announces the Kick-Off of its Next-Generation   GlobeNewswire Inc
Jan 8, 2021
09:03AM EST  Bionano Genomics Prices $88.5 Mln Public Offering Of Common Stock   RTTNews
08:45AM EST  Bionano Genomics Announces Pricing $88.5M At $3.05/Share   Benzinga
08:45AM EST  Bionano Genomics Announces Pricing of $88.5 Million Underwritten   GlobeNewswire Inc
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 7, 2021
04:02PM EST  Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock; No Terms Disclosing   Benzinga
04:01PM EST  Bionano Genomics Announces Proposed Underwritten Public Offering   GlobeNewswire Inc
Jan 5, 2021
02:33PM EST  Mid-Afternoon Market Update: Dow Climbs 250 Points; Boston Private Shares Spike Higher   Benzinga
12:21PM EST  Mid-Day Market Update: Crude Oil Surges Over 4%; Generation Bio Shares Slide   Benzinga
10:27AM EST  Mid-Morning Market Update: Markets Edge Higher; ISM Manufacturing PMI Jumps to 60.7   Benzinga
08:39AM EST  The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data   Benzinga
Jan 4, 2021
02:30PM EST  Mid-Afternoon Market Update: Dow Tumbles Over 500 Points; Calithera Biosciences Shares Slide   Benzinga
02:15PM EST  Mid-Morning Market Update: Markets Down; US Manufacturing PMI Rises To 57.1 In December   Benzinga
12:13PM EST  Mid-Day Market Update: Crude Oil Down Over 2%; The9 Shares Spike Higher   Benzinga
10:25AM EST  Return On Capital Employed Overview: Bionano Genomics   Benzinga
10:21AM EST  Mid-Morning Market Update: Markets Down; US Manufacturing PMI Rises To 57.1 In December   Benzinga
08:09AM EST  Bionano Genomics Publishes Study on Autism Risk Genes After Detailed Analysis of The Genome of Professor Temple Grandin, Who Has Brought Awareness to Autism Spectrum Disorder Through Her Activism   Benzinga
08:00AM EST  Bionano Genomics Publishes Study on Autism Risk Genes After   GlobeNewswire Inc
Dec 30, 2020
02:34PM EST  Mid-Afternoon Market Update: Dow Gains 80 Points; Osmotica Pharmaceuticals Shares Plummet   Benzinga
10:42AM EST  Shares of Bionano Genomics, Inc. (BNGO) are surging more than 70% Wednesday morning after the company said the Nasdaq granted it an additional 180-day to regain compliance with bid price rule.   RTTNews
10:24AM EST  Return On Capital Employed Overview: Bionano Genomics   Benzinga
08:16AM EST  The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data   Benzinga
08:06AM EST  Bionano Genomics Granted 180-Day Extension By Nasdaq To Regain Compliance With Bid Price Rule   Benzinga
08:00AM EST  Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021, to regain compliance with Nasdaqs minimum $1.00 closing bid price per share requirement.   GlobeNewswire Inc
Dec 29, 2020
02:26PM EST  Mid-Morning Market Update: Markets Mixed; House Passes $2,000 Direct Payments   Benzinga
02:26PM EST  Mid-Day Market Update: Crude Oil Rises 1%; Arcturus Therapeutics Shares Drop   Benzinga
10:23AM EST  Mid-Morning Market Update: Markets Mixed; House Passes $2,000 Direct Payments   Benzinga
Dec 28, 2020
09:42AM EST  Bionano Shares Up 40%; Co. Earlier Announced Its Customer, Praxis Genomics, Was Accredited By College Of American Pathologists   Benzinga
08:08AM EST  Bionano: Praxis Genomics, LLC Receive Accreditation From The College Of American Pathologists   RTTNews
08:00AM EST  Bionano Customer Praxis Genomics Accredited by College of American   GlobeNewswire Inc
Dec 23, 2020
08:03AM EST  Bionano Genomics Reports Results From Study By Human Genome Structural Variation Consortium   Benzinga
08:00AM EST  Publication Reveals in Side-by-Side Comparison that Method Using   GlobeNewswire Inc
Dec 21, 2020
08:06AM EST  Bionano Genomics Says its Saphyr System Can Process 96 Human Genomes Per Week   Benzinga
08:00AM EST  Bionano Genomics Achieves Key Milestone with Software Update for   GlobeNewswire Inc
Dec 15, 2020
08:00AM EST  Bionanos Saphyr System Used to Characterize   GlobeNewswire Inc
Dec 4, 2020
06:20AM EST  Roth Capital Downgrades Bionano Genomics to Neutral   Benzinga
Dec 3, 2020
08:00AM EST  Bionano Genomics Users Present the Saphyr System As a Novel   GlobeNewswire Inc
Nov 19, 2020
08:00AM EST  Bionano Genomics and its Users Present the Saphyr System for   GlobeNewswire Inc
Nov 12, 2020
04:04PM EST  Bionano Genomics Q3 Sales $2.20M Beat $2.07M Estimate   Benzinga
04:01PM EST  Bionano Genomics Reports Third Quarter 2020 Financial Results and   GlobeNewswire Inc
09:49AM EST  ROCE Insights For Bionano Genomics   Benzinga
08:55AM EST  Yahoo Finance Trending Stocks For Thursday, Nov. 12, 2020: XPEV, PDD, MRNA, PLTR, LI, IMAC, HYLN, EDRY, MPLN, WIX, SINO, VRM, PLUG, BLNK, UPS, BNGO, GRWG, PXS, FOSL, WWR, JD, NOW, IDEX, HIMX, INMD, NNDM, SDGR, TELL, RVLV   Benzinga
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 11, 2020
06:10PM EST  Multi-Center Evaluation of Bionano Optical Genome Mapping by   GlobeNewswire Inc
10:17AM EST  Earnings Preview for Bionano Genomics   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Oct 26, 2020
08:06AM EDT  Bionano Genomics Announces Rockefeller University Scientist Uses Co.'s Saphyr To Analyze Genomes Of Patients And Animals Susceptible To COVID-19   Benzinga
08:01AM EDT  Rockefeller University Scientist Uses Bionano Saphyr to Analyze   GlobeNewswire Inc
Oct 21, 2020
08:17AM EDT  Bionano Genomics Releases Update To Its Suite Of Software Tools   Benzinga
08:13AM EDT  Bionano Releases Major Update To Its Suite Of Software Tools   RTTNews
08:00AM EDT  Bionano Genomics Releases Major Update to Its Suite of Software   GlobeNewswire Inc
Oct 15, 2020
04:30PM EDT  Bionano Genomics' Saphyr System Shown to be Indispensable for the   GlobeNewswire Inc
08:01AM EDT  Bionano Genomics to Report Third Quarter 2020 Financial Results   GlobeNewswire Inc
Oct 12, 2020
03:55PM EDT  Bionano Genomics Shares On Watch; Co Granted Decision To Grant European Patent No. 2959015, Titled 'Characterization of molecules in nanofluidics'   Benzinga
Oct 8, 2020
08:03AM EDT  Bionano Says Co's Saphyr Plays Essential Role In Identifying Three Previously Unknown Genetic Mutation Types In Cancer In Study From Weill Cornell   Benzinga
08:00AM EDT  Bionano's Saphyr Plays Essential Role in Identifying Three   GlobeNewswire Inc
Oct 5, 2020
04:18PM EDT  Boston Children's Hospital Announces That It's Using Bionano's Saphyr To Study Children With Severe Coronavirus   Benzinga
04:15PM EDT  Boston Childrens Hospital Is Using   GlobeNewswire Inc
Sep 30, 2020
04:12PM EDT  Bionano Genomics Announces That Stockholders Voted In Favor Of A Proxy Proposal To Increase The Authorized Shares Of Its Common Stock   Benzinga
04:10PM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its stockholders have voted in favor of the companys proposal to increase the number of its authorized shares of common stock.   GlobeNewswire Inc
Sep 29, 2020
05:53PM EDT  Bionano Genomics Announces Continued Expansion of Global Business   GlobeNewswire Inc
Sep 24, 2020
08:20AM EDT  Ladenburg Thalmann Initiates Coverage On Bionano Genomics with Buy Rating, Announces Price Target of $1.25   Benzinga
08:07AM EDT  Bionano Genomics Announces MVZ Martinsried Received Accreditation For Use Of Bionano's Digital Cytogenetics Platform, Saphyr, For Laboratory Developed Tests   Benzinga
08:00AM EDT  German Accreditation of Laboratory Developed Tests on   GlobeNewswire Inc
Sep 21, 2020
08:00AM EDT  Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Erik Holmlin, Ph.D., CEO of Bionano, will present a company overview and be available for virtual one-on-one meetings with investors at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place virtually on September 21-23, 2020.   GlobeNewswire Inc
Sep 17, 2020
08:13AM EDT  Bionano Data Provides Understanding Of Repeat Expansion Disorders Causing Muscular Dystrophy And ALS   Benzinga
08:00AM EDT  Bionano Data Provides Understanding of Repeat Expansion Disorders   GlobeNewswire Inc
Sep 16, 2020
08:10AM EDT  Bionano Genomics Continues To See Expansion In The Adoption Of Saphyr For Digital Cytogenetics At Leading Medical Institutions   Benzinga
08:01AM EDT  Bionano Genomics Continues to See Expansion in the Adoption of   GlobeNewswire Inc
Sep 14, 2020
08:04AM EDT  Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen's EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy   Benzinga
08:00AM EDT  EpiPanelDxPLUS adds to Lineagens expanding menu of diagnostic tests for children with developmental disorders and provides an offering designed specifically for patients that have experienced seizures or other epilepsy-related symptoms   GlobeNewswire Inc
Sep 10, 2020
08:15AM EDT  Bionano Genomics Announces Continued Expansion Of European Business With Adoption Of Saphyr At 'Three Of Europe's Largest Pediatric Hospitals In Spain, Italy And France'   Benzinga
08:09AM EDT  Bionano Genomics Highlights Adoption Of Saphyr By Three Pediatric Hospitals In Europe   Benzinga
08:00AM EDT  Bionano Genomics Announces Continued Expansion of European   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC